Triangulates drugs with genes and pharmacogenomic biomarkers. The DruGeVar database enables the user to draw such useful conclusions from a large dataset not only by visualizing, sorting and categorizing data dynamically, but also by discovering trends across all display items and data records using different querying approaches. All DruGeVar database records depict drug/gene combinations that have been approved by any or both of the 2 major regulatory agencies, the FDA and the EMA.
Department of Pharmacy, School of Health Sciences, Patras, Greece; Department of Computer Engineering and Informatics, Faculty of Engineering, University of Patras, Patras, Greece; Department of Computer and Informatics Engineering, Technological Educational Institute of Western Greece, Patras, Greece
DruGeVar funding source(s)
This work was funded by the European Commission [REG-POT (FP285950) and RD-Connect (FP7304555)] and the Golden Helix Foundation (GHF_P1301) grants.